Glucotrack announced on Thursday that it priced a public offering of 0.17 million common shares at $2.04 per share. Certain investors will instead receive pre-funded warrants to purchase up to 1.35 million common shares at $2.039 per warrant. The offering is expected to generate gross proceeds of about $3.1 million. The deal was priced at market under Nasdaq rules and is expected to close around Sept. 25, with Dawson James Securities acting as the sole placement agent. Shares rose 31.53 percent.
GlucoTrack IncGlucoTrack priced a $3.1M public offering at $2.04/share, a dilutive equity financing.
